1

Dianabol Cycle: FAQs And Harm Reduction Protocols

stephany28w720 edited this page 2025-10-08 13:39:56 +02:00

This file contains invisible Unicode characters

This file contains invisible Unicode characters that are indistinguishable to humans but may be processed differently by a computer. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

Dianabol Cycle: FAQs And Harm Reduction Protocols
Clinical presentation / age of onset – MPS IIIa (Sanfilippo type A)

FeatureWhat the literature says Typical age when first signs appearThe article notes that symptoms "may be present early in life," but it does not provide a specific age range or average. In clinical practice, manifestations usually become apparent between 2–4 years of age (often earlier for more severe variants). Early‑onset symptomsThe review lists the classic neuro‑cognitive phenotype—progressive intellectual decline and behavioral changes—but does not detail the earliest specific signs (e.g., speech delay, sleep disturbances). Onset of motor/neurological deficitsNo age data is given